Dàta Tuarastail H-1B

Dachaigh › Gnìomhan › Molecular and Cellular Biologists › Pittsburgh, PA

Molecular and Cellular Biologists ann an Pittsburgh, PA: Tuarastalan H-1B

123 iarrtasan cumhaichean-obrach airson an dreuchd seo le làrach-obrach ann an Pittsburgh, PA. Tuarastal bunasach meadhanach $64,380; leth meadhanach $59,615–$80,059.

Iarrtasan (LCAs)123
Tuarastal meadhanach a chaidh a thabhann$64,380
Leath mheadhanach nan tuarastalan$59,615–$80,059
Ceudail 10mh–90mh$54,987–$102,064

A rèir ìre tuarastail

Ìre tuarastailTuarastal meadhanach
Ìre I (innte)$62,533
Ìre II (càileachail)$77,262
Ìre III (eòlach)$86,500
Ìre IV (gu lèir comasach)$110,000

Suidhichidh Roinn an Obrach ceithir ìrean tuarastail làithreach airson gach dreuchd agus sgìre, bho Ìre I (inntrigeadh) gu Ìre IV (gu tur comasach). Taghaidh an neach-fastaidh an ìre a fhreagras ri riatanasan na h-obrach.

Luchd-fastaidh

Neach-obrachLCAsTuarastal meadhanach
University of Pittsburgh82$63,120
Carnegie Mellon University20$64,890
UPMC Medical Education3$74,523
Open Avenues Foundation2—
UPMC Presbyterian Shadyside2$58,314
Allegheny Singer Research Institute2$55,500
Signature Diagnostics Inc2$65,000
Laboratory Corporation of America1$130,000
Microbial Genome Sequencing Center, LLC1$90,000
Perkinelmer Genetics Inc.1$84,032
Laboratory Corporation of America Holdings1$130,000
Astrata, Inc.1$150,157
University of Pittsburgh Physicians1—
Interpace Diagnostics Group, Inc.1$104,900
Geisinger Clinic1$70,429
University of North Carolina at Chapel Hill1$110,000
Northwest Biotherapeutics, Inc.1$99,070

Tiotalan dreuchd

Luchd-taic H-1B ann an Pittsburgh, PA →

Is e na tuarastalan an ìre as ìsle den tuarastal a chaidh a thabhann air gach iarrtas, air an tionndadh gu suim bhliadhnail; cleachdaidh na staitistigean iarrtasan làn-aimsire le teisteanas a-mhàin. Chan eil LCA na aontachadh bhìosa agus faodaidh aon LCA còmhdach a dhèanamh air iomadh dreuchd. Stòr: Roinn an Obrach na SA, Dàta Foillseachaidh OFLC LCA, bliadhnaichean ionmhais 2023–2026 (co-dhùnadh as ùire 30 Ògmh 2026).